296 related articles for article (PubMed ID: 30382083)
1. PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma.
Dong F; Li Q; Yang C; Huo D; Wang X; Ai C; Kong Y; Sun X; Wang W; Zhou Y; Liu X; Li W; Gao W; Liu W; Kang C; Wu X
Nat Commun; 2018 Oct; 9(1):4552. PubMed ID: 30382083
[TBL] [Abstract][Full Text] [Related]
2. PRMT2 accelerates tumorigenesis of hepatocellular carcinoma by activating Bcl2 via histone H3R8 methylation.
Hu G; Yan C; Xie P; Cao Y; Shao J; Ge J
Exp Cell Res; 2020 Sep; 394(2):112152. PubMed ID: 32574605
[TBL] [Abstract][Full Text] [Related]
3. Protein arginine methyltransferase 2 (PRMT2) promotes dextran sulfate sodium-induced colitis by inhibiting the SOCS3 promoter via histone H3R8 asymmetric dimethylation.
Li J; Pan X; Ren Z; Li B; Liu H; Wu C; Dong X; de Vos P; Pan LL; Sun J
Br J Pharmacol; 2022 Jan; 179(1):141-158. PubMed ID: 34599829
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible PRMT2 addiction in glioblastomas.
Dong F; Sun X; Su J; Li Q; He Y; Li W; Wang B; Wang B; Xu G; Wu X
Cell Signal; 2024 May; 117():111094. PubMed ID: 38341123
[TBL] [Abstract][Full Text] [Related]
5. PRMT2 promotes RCC tumorigenesis and metastasis via enhancing WNT5A transcriptional expression.
Li Z; Chen C; Yong H; Jiang L; Wang P; Meng S; Chu S; Li Z; Guo Q; Zheng J; Bai J; Li H
Cell Death Dis; 2023 May; 14(5):322. PubMed ID: 37173306
[TBL] [Abstract][Full Text] [Related]
6. Protein arginine N-methyltransferase 2 plays a noncatalytic role in the histone methylation activity of PRMT1.
Rowley MJ; Prout-Holm RA; Liu RW; Hendrickson-Rebizant T; Ige OO; Lakowski TM; Frankel A
J Biol Chem; 2023 Dec; 299(12):105360. PubMed ID: 37863263
[TBL] [Abstract][Full Text] [Related]
7. Targeting of BMI-1 with PTC-209 inhibits glioblastoma development.
Kong Y; Ai C; Dong F; Xia X; Zhao X; Yang C; Kang C; Zhou Y; Zhao Q; Sun X; Wu X
Cell Cycle; 2018; 17(10):1199-1211. PubMed ID: 29886801
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma.
Zhong J; Cao RX; Zu XY; Hong T; Yang J; Liu L; Xiao XH; Ding WJ; Zhao Q; Liu JH; Wen GB
FEBS J; 2012 Jan; 279(2):316-35. PubMed ID: 22093364
[TBL] [Abstract][Full Text] [Related]
9. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
10. PRMT2 and RORγ expression are associated with breast cancer survival outcomes.
Oh TG; Bailey P; Dray E; Smith AG; Goode J; Eriksson N; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Clarke CL; Grimmond S; Dowhan DH; Muscat GE
Mol Endocrinol; 2014 Jul; 28(7):1166-85. PubMed ID: 24911119
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of human protein arginine N-methyltransferase 2: formation of monomethyl- and asymmetric dimethyl-arginine residues on histone H4.
Lakowski TM; Frankel A
Biochem J; 2009 Jun; 421(2):253-61. PubMed ID: 19405910
[TBL] [Abstract][Full Text] [Related]
12. WDR5-Myc axis promotes the progression of glioblastoma and neuroblastoma by transcriptional activating CARM1.
Wang F; Zhang J; Ke X; Peng W; Zhao G; Peng S; Xu J; Xu B; Cui H
Biochem Biophys Res Commun; 2020 Mar; 523(3):699-706. PubMed ID: 31948749
[TBL] [Abstract][Full Text] [Related]
13. Nuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein.
Zhong J; Cao RX; Liu JH; Liu YB; Wang J; Liu LP; Chen YJ; Yang J; Zhang QH; Wu Y; Ding WJ; Hong T; Xiao XH; Zu XY; Wen GB
Oncogene; 2014 Nov; 33(48):5546-58. PubMed ID: 24292672
[TBL] [Abstract][Full Text] [Related]
14. Arginine Methylation by PRMT2 Controls the Functions of the Actin Nucleator Cobl.
Hou W; Nemitz S; Schopper S; Nielsen ML; Kessels MM; Qualmann B
Dev Cell; 2018 Apr; 45(2):262-275.e8. PubMed ID: 29689199
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between DNA methylation and histone acetylation triggers GDNF high transcription in glioblastoma cells.
Zhang B; Gu X; Han X; Gao Q; Liu J; Guo T; Gao D
Clin Epigenetics; 2020 Mar; 12(1):47. PubMed ID: 32183903
[TBL] [Abstract][Full Text] [Related]
16. SH3BGRL3, transcribed by STAT3, facilitates glioblastoma tumorigenesis by activating STAT3 signaling.
Nie Z; Cheng D; Pan C; Wei Z; Wang C; Wang C
Biochem Biophys Res Commun; 2021 Jun; 556():114-120. PubMed ID: 33839406
[TBL] [Abstract][Full Text] [Related]
17. Sprouty2 enhances the tumorigenic potential of glioblastoma cells.
Park JW; Wollmann G; Urbiola C; Fogli B; Florio T; Geley S; Klimaschewski L
Neuro Oncol; 2018 Jul; 20(8):1044-1054. PubMed ID: 29635363
[TBL] [Abstract][Full Text] [Related]
18. PRMT2β, a C-terminal splice variant of PRMT2, inhibits the growth of breast cancer cells.
Zhong J; Chen YJ; Chen L; Shen YY; Zhang QH; Yang J; Cao RX; Zu XY; Wen GB
Oncol Rep; 2017 Aug; 38(2):1303-1311. PubMed ID: 28677794
[TBL] [Abstract][Full Text] [Related]
19. The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically.
Yu Z; Feng J; Wang W; Deng Z; Zhang Y; Xiao L; Wang Z; Liu C; Liu Q; Chen S; Wu M
Oncogene; 2020 Apr; 39(15):3163-3178. PubMed ID: 32051553
[TBL] [Abstract][Full Text] [Related]
20. RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1.
Yu H; Zhang S; Ibrahim AN; Wang J; Deng Z; Wang M
Biochem Biophys Res Commun; 2019 Aug; 516(3):999-1006. PubMed ID: 31277942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
